aluates Reports

$ 0.0

Automative

Global Geographic Atrophy Drugs Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-28H18133

BUY CHAPTERS

Global Geographic Atrophy Drugs Market Research Report 2024

Code: QYRE-Auto-28H18133

Report

October 2024

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AMD

Apellis Pharmaceuticals

Astellas Pharma

Geographic Atrophy Drugs Market

Geographic atrophy (GA) drugs are therapies aimed at treating geographic atrophy, an advanced form of age-related macular degeneration (AMD) characterized by progressive degeneration of retinal cells, leading to vision loss. These drugs typically target the complement system, which plays a crucial role in inflammation and retinal damage.By blocking different stages of the complement cascade, these drugs aim to slow down the progression of GA, protecting the retina from further damage and preserving vision for as long as possible.

The global Geographic Atrophy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Geographic Atrophy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Geographic Atrophy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Geographic Atrophy Drugs include Apellis Pharmaceuticals, Astellas Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Geographic Atrophy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geographic Atrophy Drugs.

The Geographic Atrophy Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Geographic Atrophy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Geographic Atrophy Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Geographic Atrophy Drugs Market Report

Report Metric	Details
Report Name	Geographic Atrophy Drugs Market
Segment by Type	Avacincaptad Pegcetacoplan Other
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Apellis Pharmaceuticals, Astellas Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Geographic Atrophy Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Geographic Atrophy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Geographic Atrophy Drugs Market report?

Ans: The main players in the Geographic Atrophy Drugs Market are Apellis Pharmaceuticals, Astellas Pharma

What are the Application segmentation covered in the Geographic Atrophy Drugs Market report?

Ans: The Applications covered in the Geographic Atrophy Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Geographic Atrophy Drugs Market report?

Ans: The Types covered in the Geographic Atrophy Drugs Market report are Avacincaptad, Pegcetacoplan, Other

Recommended Reports

Ophthalmology Drugs

Retina & Macular

Neurodegenerative Disorders

1 Geographic Atrophy Drugs Market Overview

1.1 Product Definition

1.2 Geographic Atrophy Drugs by Type

1.2.1 Global Geographic Atrophy Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Avacincaptad

1.2.3 Pegcetacoplan

1.2.4 Other

1.3 Geographic Atrophy Drugs by Application

1.3.1 Global Geographic Atrophy Drugs Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Geographic Atrophy Drugs Market Size Estimates and Forecasts

1.4.1 Global Geographic Atrophy Drugs Revenue 2019-2030

1.4.2 Global Geographic Atrophy Drugs Sales 2019-2030

1.4.3 Global Geographic Atrophy Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Geographic Atrophy Drugs Market Competition by Manufacturers

2.1 Global Geographic Atrophy Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Geographic Atrophy Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Geographic Atrophy Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Geographic Atrophy Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Geographic Atrophy Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Geographic Atrophy Drugs, Product Type & Application

2.7 Global Key Manufacturers of Geographic Atrophy Drugs, Date of Enter into This Industry

2.8 Global Geographic Atrophy Drugs Market Competitive Situation and Trends

2.8.1 Global Geographic Atrophy Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Geographic Atrophy Drugs Players Market Share by Revenue

2.8.3 Global Geographic Atrophy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Geographic Atrophy Drugs Market Scenario by Region

3.1 Global Geographic Atrophy Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Geographic Atrophy Drugs Sales by Region: 2019-2030

3.2.1 Global Geographic Atrophy Drugs Sales by Region: 2019-2024

3.2.2 Global Geographic Atrophy Drugs Sales by Region: 2025-2030

3.3 Global Geographic Atrophy Drugs Revenue by Region: 2019-2030

3.3.1 Global Geographic Atrophy Drugs Revenue by Region: 2019-2024

3.3.2 Global Geographic Atrophy Drugs Revenue by Region: 2025-2030

3.4 North America Geographic Atrophy Drugs Market Facts & Figures by Country

3.4.1 North America Geographic Atrophy Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Geographic Atrophy Drugs Sales by Country (2019-2030)

3.4.3 North America Geographic Atrophy Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Geographic Atrophy Drugs Market Facts & Figures by Country

3.5.1 Europe Geographic Atrophy Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Geographic Atrophy Drugs Sales by Country (2019-2030)

3.5.3 Europe Geographic Atrophy Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Geographic Atrophy Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Geographic Atrophy Drugs Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Geographic Atrophy Drugs Sales by Region (2019-2030)

3.6.3 Asia Pacific Geographic Atrophy Drugs Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Geographic Atrophy Drugs Market Facts & Figures by Country

3.7.1 Latin America Geographic Atrophy Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Geographic Atrophy Drugs Sales by Country (2019-2030)

3.7.3 Latin America Geographic Atrophy Drugs Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Geographic Atrophy Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Geographic Atrophy Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Geographic Atrophy Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Geographic Atrophy Drugs Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Geographic Atrophy Drugs Sales by Type (2019-2030)

4.1.1 Global Geographic Atrophy Drugs Sales by Type (2019-2024)

4.1.2 Global Geographic Atrophy Drugs Sales by Type (2025-2030)

4.1.3 Global Geographic Atrophy Drugs Sales Market Share by Type (2019-2030)

4.2 Global Geographic Atrophy Drugs Revenue by Type (2019-2030)

4.2.1 Global Geographic Atrophy Drugs Revenue by Type (2019-2024)

4.2.2 Global Geographic Atrophy Drugs Revenue by Type (2025-2030)

4.2.3 Global Geographic Atrophy Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Geographic Atrophy Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Geographic Atrophy Drugs Sales by Application (2019-2030)

5.1.1 Global Geographic Atrophy Drugs Sales by Application (2019-2024)

5.1.2 Global Geographic Atrophy Drugs Sales by Application (2025-2030)

5.1.3 Global Geographic Atrophy Drugs Sales Market Share by Application (2019-2030)

5.2 Global Geographic Atrophy Drugs Revenue by Application (2019-2030)

5.2.1 Global Geographic Atrophy Drugs Revenue by Application (2019-2024)

5.2.2 Global Geographic Atrophy Drugs Revenue by Application (2025-2030)

5.2.3 Global Geographic Atrophy Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Geographic Atrophy Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Apellis Pharmaceuticals

6.1.1 Apellis Pharmaceuticals Company Information

6.1.2 Apellis Pharmaceuticals Description and Business Overview

6.1.3 Apellis Pharmaceuticals Geographic Atrophy Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Apellis Pharmaceuticals Geographic Atrophy Drugs Product Portfolio

6.1.5 Apellis Pharmaceuticals Recent Developments/Updates

6.2 Astellas Pharma

6.2.1 Astellas Pharma Company Information

6.2.2 Astellas Pharma Description and Business Overview

6.2.3 Astellas Pharma Geographic Atrophy Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Astellas Pharma Geographic Atrophy Drugs Product Portfolio

6.2.5 Astellas Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Geographic Atrophy Drugs Industry Chain Analysis

7.2 Geographic Atrophy Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Geographic Atrophy Drugs Production Mode & Process

7.4 Geographic Atrophy Drugs Sales and Marketing

7.4.1 Geographic Atrophy Drugs Sales Channels

7.4.2 Geographic Atrophy Drugs Distributors

7.5 Geographic Atrophy Drugs Customers

8 Geographic Atrophy Drugs Market Dynamics

8.1 Geographic Atrophy Drugs Industry Trends

8.2 Geographic Atrophy Drugs Market Drivers

8.3 Geographic Atrophy Drugs Market Challenges

8.4 Geographic Atrophy Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

AMD

Apellis Pharmaceuticals

Astellas Pharma

List of Tables

Table 1. Global Geographic Atrophy Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Geographic Atrophy Drugs Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Geographic Atrophy Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Geographic Atrophy Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Geographic Atrophy Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Geographic Atrophy Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Geographic Atrophy Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Geographic Atrophy Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Geographic Atrophy Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Geographic Atrophy Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Geographic Atrophy Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Geographic Atrophy Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Geographic Atrophy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Geographic Atrophy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Geographic Atrophy Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Geographic Atrophy Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Geographic Atrophy Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Geographic Atrophy Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Geographic Atrophy Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Geographic Atrophy Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Geographic Atrophy Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Geographic Atrophy Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Geographic Atrophy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Geographic Atrophy Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Geographic Atrophy Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Geographic Atrophy Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Geographic Atrophy Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Geographic Atrophy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Geographic Atrophy Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Geographic Atrophy Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Geographic Atrophy Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Geographic Atrophy Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Geographic Atrophy Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Geographic Atrophy Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Geographic Atrophy Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Geographic Atrophy Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Geographic Atrophy Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Geographic Atrophy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Geographic Atrophy Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Geographic Atrophy Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Geographic Atrophy Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Geographic Atrophy Drugs Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Geographic Atrophy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Geographic Atrophy Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Geographic Atrophy Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Geographic Atrophy Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Geographic Atrophy Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Geographic Atrophy Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Geographic Atrophy Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Geographic Atrophy Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Geographic Atrophy Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Geographic Atrophy Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Geographic Atrophy Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Geographic Atrophy Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Geographic Atrophy Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Geographic Atrophy Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Geographic Atrophy Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Geographic Atrophy Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Geographic Atrophy Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Geographic Atrophy Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Geographic Atrophy Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Geographic Atrophy Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Geographic Atrophy Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Geographic Atrophy Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Geographic Atrophy Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Geographic Atrophy Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Geographic Atrophy Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Apellis Pharmaceuticals Company Information

Table 71. Apellis Pharmaceuticals Description and Business Overview

Table 72. Apellis Pharmaceuticals Geographic Atrophy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Apellis Pharmaceuticals Geographic Atrophy Drugs Product

Table 74. Apellis Pharmaceuticals Recent Developments/Updates

Table 75. Astellas Pharma Company Information

Table 76. Astellas Pharma Description and Business Overview

Table 77. Astellas Pharma Geographic Atrophy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Astellas Pharma Geographic Atrophy Drugs Product

Table 79. Astellas Pharma Recent Developments/Updates

Table 80. Key Raw Materials Lists

Table 81. Raw Materials Key Suppliers Lists

Table 82. Geographic Atrophy Drugs Distributors List

Table 83. Geographic Atrophy Drugs Customers List

Table 84. Geographic Atrophy Drugs Market Trends

Table 85. Geographic Atrophy Drugs Market Drivers

Table 86. Geographic Atrophy Drugs Market Challenges

Table 87. Geographic Atrophy Drugs Market Restraints

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Product Picture of Geographic Atrophy Drugs

Figure 2. Global Geographic Atrophy Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Geographic Atrophy Drugs Market Share by Type: 2023 & 2030

Figure 4. Avacincaptad Product Picture

Figure 5. Pegcetacoplan Product Picture

Figure 6. Other Product Picture

Figure 7. Global Geographic Atrophy Drugs Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Geographic Atrophy Drugs Market Share by Application: 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Geographic Atrophy Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Geographic Atrophy Drugs Market Size (2019-2030) & (US$ Million)

Figure 14. Global Geographic Atrophy Drugs Sales (2019-2030) & (K Units)

Figure 15. Global Geographic Atrophy Drugs Average Price (US$/Unit) & (2019-2030)

Figure 16. Geographic Atrophy Drugs Report Years Considered

Figure 17. Geographic Atrophy Drugs Sales Share by Manufacturers in 2023

Figure 18. Global Geographic Atrophy Drugs Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Geographic Atrophy Drugs Players: Market Share by Revenue in Geographic Atrophy Drugs in 2023

Figure 20. Geographic Atrophy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Geographic Atrophy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Geographic Atrophy Drugs Sales Market Share by Country (2019-2030)

Figure 23. North America Geographic Atrophy Drugs Revenue Market Share by Country (2019-2030)

Figure 24. United States Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Geographic Atrophy Drugs Sales Market Share by Country (2019-2030)

Figure 27. Europe Geographic Atrophy Drugs Revenue Market Share by Country (2019-2030)

Figure 28. Germany Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Geographic Atrophy Drugs Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Geographic Atrophy Drugs Revenue Market Share by Region (2019-2030)

Figure 35. China Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Geographic Atrophy Drugs Sales Market Share by Country (2019-2030)

Figure 43. Mexico Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Geographic Atrophy Drugs Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Geographic Atrophy Drugs Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Geographic Atrophy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Geographic Atrophy Drugs by Type (2019-2030)

Figure 53. Global Revenue Market Share of Geographic Atrophy Drugs by Type (2019-2030)

Figure 54. Global Geographic Atrophy Drugs Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Geographic Atrophy Drugs by Application (2019-2030)

Figure 56. Global Revenue Market Share of Geographic Atrophy Drugs by Application (2019-2030)

Figure 57. Global Geographic Atrophy Drugs Price (US$/Unit) by Application (2019-2030)

Figure 58. Geographic Atrophy Drugs Value Chain

Figure 59. Geographic Atrophy Drugs Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Geographic Atrophy Market Research Report 2025

Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024

Global Anti amyloid Therapy Market Research Report 2024

Global Retinitis Pigmentosa Treatment Market Research Report 2024

Global Anti amyloid Drugs Market Research Report 2024

Global Anti VEGF Drugs for the Treatment of Wet AMD Market Research Report 2024

Global Multiple System Atrophy Therapeutics Market Research Report 2024

Global Anti VEGF Ophthalmic Drugs Market Research Report 2024

Global Anti VEGT Drugs Market Research Report 2024

Global Macular Degeneration Treatment Market Research Report 2024

Retinal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions